Roche (OTCMKTS:RHHBY) Reaches New 52-Week High – Time to Buy?

Shares of Roche Holding AG (OTCMKTS:RHHBY) reached a new 52-week high on Tuesday . The company traded as high as $53.90 and last traded at $53.20, with a volume of 3080095 shares. The stock had previously closed at $53.40.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on RHHBY shares. JPMorgan Chase & Co. raised shares of Roche from an “underweight” rating to a “neutral” rating in a research report on Monday, December 8th. HSBC reiterated a “buy” rating and set a $57.00 price target on shares of Roche in a research note on Wednesday, December 10th. Zacks Research upgraded Roche from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Morgan Stanley reiterated an “underweight” rating on shares of Roche in a report on Tuesday, December 2nd. Finally, Hsbc Global Res upgraded Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 2nd. Three research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $57.00.

Roche Stock Up 1.2%

The business has a 50 day simple moving average of $49.46 and a 200-day simple moving average of $44.16. The company has a debt-to-equity ratio of 0.80, a current ratio of 1.29 and a quick ratio of 1.02.

Institutional Trading of Roche

Several hedge funds have recently added to or reduced their stakes in RHHBY. GAMMA Investing LLC boosted its stake in Roche by 25.3% in the second quarter. GAMMA Investing LLC now owns 16,101 shares of the company’s stock valued at $656,000 after acquiring an additional 3,251 shares during the last quarter. Boston Common Asset Management LLC raised its holdings in shares of Roche by 11.1% in the 2nd quarter. Boston Common Asset Management LLC now owns 361,833 shares of the company’s stock worth $14,682,000 after purchasing an additional 36,101 shares during the period. OLD National Bancorp IN lifted its stake in Roche by 2.9% in the second quarter. OLD National Bancorp IN now owns 261,317 shares of the company’s stock valued at $10,604,000 after purchasing an additional 7,326 shares during the last quarter. Yousif Capital Management LLC grew its holdings in Roche by 7.8% during the second quarter. Yousif Capital Management LLC now owns 88,547 shares of the company’s stock valued at $3,593,000 after purchasing an additional 6,395 shares during the period. Finally, Verity Asset Management Inc. increased its position in Roche by 12.5% in the second quarter. Verity Asset Management Inc. now owns 9,092 shares of the company’s stock worth $371,000 after buying an additional 1,008 shares during the last quarter.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.